230 related articles for article (PubMed ID: 8384126)
21. Purification and characterization of a bone metalloproteinase that degrades gelatin and types IV and V collagen.
Murphy G; McAlpine CG; Poll CT; Reynolds JJ
Biochim Biophys Acta; 1985 Sep; 831(1):49-58. PubMed ID: 2994741
[TBL] [Abstract][Full Text] [Related]
22. Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis.
Zeng ZS; Cohen AM; Guillem JG
Carcinogenesis; 1999 May; 20(5):749-55. PubMed ID: 10334190
[TBL] [Abstract][Full Text] [Related]
23. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2).
Fridman R; Toth M; Peña D; Mobashery S
Cancer Res; 1995 Jun; 55(12):2548-55. PubMed ID: 7780967
[TBL] [Abstract][Full Text] [Related]
24. Application of N-carboxyalkyl peptides to the inhibition and affinity purification of the porcine matrix metalloproteinases collagenase, gelatinase, and stromelysin.
Stack MS; Emberts CG; Gray RD
Arch Biochem Biophys; 1991 Jun; 287(2):240-9. PubMed ID: 1654808
[TBL] [Abstract][Full Text] [Related]
25. Mosaic structure of the secreted ECM metalloproteases and interaction of the type IV collagenases with inhibitors.
Goldberg GI; Collier IE; Eisen AZ; Grant GA; Marmer BL; Wilhelm SM
Matrix Suppl; 1992; 1():25-30. PubMed ID: 1336109
[TBL] [Abstract][Full Text] [Related]
26. Expression pattern of matrix metalloproteinases in human liver.
Lichtinghagen R; Helmbrecht T; Arndt B; Böker KH
Eur J Clin Chem Clin Biochem; 1995 Feb; 33(2):65-71. PubMed ID: 7632822
[TBL] [Abstract][Full Text] [Related]
27. The purification of tissue inhibitor of metalloproteinases-2 from its 72 kDa progelatinase complex. Demonstration of the biochemical similarities of tissue inhibitor of metalloproteinases-2 and tissue inhibitor of metalloproteinases-1.
Ward RV; Hembry RM; Reynolds JJ; Murphy G
Biochem J; 1991 Aug; 278 ( Pt 1)(Pt 1):179-87. PubMed ID: 1909113
[TBL] [Abstract][Full Text] [Related]
28. Characterization of metalloproteinases and tissue inhibitors of metalloproteinases in human plasma.
Moutsiakis D; Mancuso P; Krutzsch H; Stetler-Stevenson W; Zucker S
Connect Tissue Res; 1992; 28(3):213-30. PubMed ID: 1468208
[TBL] [Abstract][Full Text] [Related]
29. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.
Galis ZS; Sukhova GK; Lark MW; Libby P
J Clin Invest; 1994 Dec; 94(6):2493-503. PubMed ID: 7989608
[TBL] [Abstract][Full Text] [Related]
30. Concanavalin A produces a matrix-degradative phenotype in human fibroblasts. Induction and endogenous activation of collagenase, 72-kDa gelatinase, and Pump-1 is accompanied by the suppression of the tissue inhibitor of matrix metalloproteinases.
Overall CM; Sodek J
J Biol Chem; 1990 Dec; 265(34):21141-51. PubMed ID: 2174435
[TBL] [Abstract][Full Text] [Related]
31. Latent collagenase and gelatinase from human neutrophils and their activation.
Tschesche H; Knäuper V; Krämer S; Michaelis J; Oberhoff R; Reinke H
Matrix Suppl; 1992; 1():245-55. PubMed ID: 1480034
[TBL] [Abstract][Full Text] [Related]
32. Tumor promoter-stimulated Mr 92,000 gelatinase secreted by normal and malignant human cells: isolation and characterization of the enzyme from HT1080 tumor cells.
Moll UM; Youngleib GL; Rosinski KB; Quigley JP
Cancer Res; 1990 Oct; 50(19):6162-70. PubMed ID: 2169335
[TBL] [Abstract][Full Text] [Related]
33. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines.
Mackay AR; Ballin M; Pelina MD; Farina AR; Nason AM; Hartzler JL; Thorgeirsson UP
Invasion Metastasis; 1992; 12(3-4):168-84. PubMed ID: 1284126
[TBL] [Abstract][Full Text] [Related]
34. Characterization of matrix metalloproteinases in human urine: alterations during adolescence.
Thrailkill KM; Kumar S; Rosenberg CK; Auten KJ; Fowlkes JL
Pediatr Nephrol; 1999 Apr; 13(3):223-9. PubMed ID: 10353410
[TBL] [Abstract][Full Text] [Related]
35. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
[TBL] [Abstract][Full Text] [Related]
36. Activation of gelatinase-tissue-inhibitors-of-metalloproteinase complexes by matrilysin.
von Bredow DC; Cress AE; Howard EW; Bowden GT; Nagle RB
Biochem J; 1998 May; 331 ( Pt 3)(Pt 3):965-72. PubMed ID: 9560329
[TBL] [Abstract][Full Text] [Related]
37. HL-60 leukemia cells produce an autocatalytically truncated form of matrix metalloproteinase-9 with impaired sensitivity to inhibition by tissue inhibitors of metalloproteinases.
Ries C; Lottspeich F; Dittmann KH; Petrides PE
Leukemia; 1996 Sep; 10(9):1520-6. PubMed ID: 8751473
[TBL] [Abstract][Full Text] [Related]
38. Partial purification of collagenase and gelatinase from human polymorphonuclear leucocytes. Analysis of their actions on soluble and insoluble collagens.
Murphy G; Reynolds JJ; Bretz U; Baggiolini M
Biochem J; 1982 Apr; 203(1):209-21. PubMed ID: 6285893
[TBL] [Abstract][Full Text] [Related]
39. Increased type IV collagen-degrading activity in metastases originating from primary tumors of the human colon.
Karakiulakis G; Papanikolaou C; Jankovic SM; Aletras A; Papakonstantinou E; Vretou E; Mirtsou-Fidani V
Invasion Metastasis; 1997; 17(3):158-68. PubMed ID: 9702942
[TBL] [Abstract][Full Text] [Related]
40. Extracellular matrix binding properties of recombinant fibronectin type II-like modules of human 72-kDa gelatinase/type IV collagenase. High affinity binding to native type I collagen but not native type IV collagen.
Steffensen B; Wallon UM; Overall CM
J Biol Chem; 1995 May; 270(19):11555-66. PubMed ID: 7744795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]